noscript

News and Announcements

Blue Sky Biologicals Secures $10M Supply Agreement for their New ‘Golden Harvest’ CBD Formula

  • Published December 15, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • Long-term supply contract generates sustainable revenues for 2018 and the future.
  • Blue Sky’s ‘Golden Harvest’ is 100% organically produced pure CBD’s, offering our clients a consistent supply of one of the highest pharma-grade product.
  • Several additional agreements have been signed for co-manufacturing global CBD based products for clients.

Blue Sky Biologicals is pleased to announce several long-term agreements to supply both wholesale and finished CBD products to key global clients the company has been working with over the last year.

With the release of our purest CBD formula to date, ‘Golden Harvest’ the company is exceeding client expectations of quality and consistent supply.

An initial wholesale agreement for $10M USD, over the next 3 quarters of 2018, stems from an ongoing relationship to co-manufacture finished CBD products, utilizing ‘Golden Harvest’ with a key US distributor and represents a strong source of early revenues for Blue Sky. The Company continues to work with global partners to fulfil their organic CDB requirements to the benefit of all parties and end customers.

 

About Blue Sky Biologicals Inc.

BSB, has a joint venture partnership providing the worlds largest supply of CBD formulations and products globally with 20,000 acres of hemp growth and is expanding into facilities exceeding 300,000 sq ft for production & extraction. Over the last four years the founders of BSB have developed several key IP based CBD formulas and products that are now market ready with several international agreements in place to launch products or co-manufacture formulations for existing vendors & distributors.

Request Offer

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now